DI DONNA, MARTINA GAIA
DI DONNA, MARTINA GAIA
Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer's Disease
2024-01-01 Bonomi, C; Motta, C; DI DONNA, Mg; Poli, M; Nuccetelli, M; Bernardini, S; Mercuri, N; Koch, G; Martorana, A
Beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies
2025-01-01 Poli, M; Bonomi, Cg; Tretola, L; Rosa, M; Di Donna, Mg; Moreschini, A; Nuccetelli, M; Bernardini, S; Mercuri, Nb; Martorana, A; Motta, C
Blood–brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease
2024-01-01 Bruno, M; Bonomi, Cg; Ricci, F; Di , ; Donna, Mg; Mercuri, Nb; Koch, G; Martorana, A; Motta, C
Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum.
2023-04-01 Bonomi, C; Assogna, M; Di Donna, Mg; Bernocchi, F; De Lucia, V; Nuccetelli, M; Fiorelli, D; Loizzo, S; Mercuri, N; Koch, G; Martorana, A; Motta, C
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
2023-08-30 Motta, C; Di Donna, Mg; Bonomi, Cg; Assogna, M; Chiaravalloti, A; Mercuri, Nb; Koch, G; Martorana, A
Lecanemab’s Path Forward: Navigating the Future of Alzheimer’s Treatment in Europe Amidst the EMA's Rejection
2024-01-01 Martorana, A; Bonomi, Cg; Di Donna, Mg; Motta, C
NOTCH3 variants of unknown significance underpin vascular dysfunction in neurodegenerative disease: a case series of three nfvPPA-FTD patients
2025-01-01 Di Donna, Mg; Colona, Vl; Bagnato, Mr; Bonomi, Cg; Tirrito, L; Marchionni, E; Motta, C; Sangiuolo, Fc; Martorana, A
Opposing patterns of blood-brain barrier permeability and Alzheimer’s disease biomarkers across APOE genotype
2026-01-01 Bernocchi, F; Bonomi, Cg; Giuseppina, C; Poli, M; Di, D; Gaia, M; Terrinoni, A; Motta, C; Martorana, A
Reframing TDP‐43 in Alzheimer's disease: From co‐pathology to neurovascular culprit
2025-01-01 Di Donna, Mg; Motta, C; Bonomi, Cg; Bernocchi, F; Ricci, F; Poli, M; Koch, G; Martorana, A
Reply to: letter to the editor regarding “beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies”
2025-01-01 Poli, M; Bonomi, Cg; Di Donna, Mg; Motta, C; Martorana, A
Rethinking dementia in the oldest old: Lessons to learn for the diagnosis and treatment of Alzheimer’s disease
2025-01-01 Bonomi, Cg; Motta, C; Di Donna, Mg; Poli, M; Koch, G; Martorana, A
Streamlining Alzheimer's disease diagnosis: real-world validation of two-cut-off diagnostic models based on plasma p-tau/Aβ42 ratios
2026-01-01 Poli, M; Bonomi, C; Di Donna, Mg; Barberis, I; Ginevra, E; Nuccetelli, M; Bernardini, S; Centonze, D; Martorana, A; Motta, C
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2024 | Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer's Disease | Bonomi, C; Motta, C; DI DONNA, Mg; Poli, M; Nuccetelli, M; Bernardini, S; Mercuri, N; Koch, G; Martorana, A | Articolo su rivista | |
| 1-gen-2025 | Beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies | Poli, M; Bonomi, Cg; Tretola, L; Rosa, M; Di Donna, Mg; Moreschini, A; Nuccetelli, M; Bernardini, S; Mercuri, Nb; Martorana, A; Motta, C | Articolo su rivista | |
| 1-gen-2024 | Blood–brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease | Bruno, M; Bonomi, Cg; Ricci, F; Di , ; Donna, Mg; Mercuri, Nb; Koch, G; Martorana, A; Motta, C | Articolo su rivista | |
| 1-apr-2023 | Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum. | Bonomi, C; Assogna, M; Di Donna, Mg; Bernocchi, F; De Lucia, V; Nuccetelli, M; Fiorelli, D; Loizzo, S; Mercuri, N; Koch, G; Martorana, A; Motta, C | Articolo su rivista | |
| 30-ago-2023 | Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study | Motta, C; Di Donna, Mg; Bonomi, Cg; Assogna, M; Chiaravalloti, A; Mercuri, Nb; Koch, G; Martorana, A | Articolo su rivista | |
| 1-gen-2024 | Lecanemab’s Path Forward: Navigating the Future of Alzheimer’s Treatment in Europe Amidst the EMA's Rejection | Martorana, A; Bonomi, Cg; Di Donna, Mg; Motta, C | Articolo su rivista | |
| 1-gen-2025 | NOTCH3 variants of unknown significance underpin vascular dysfunction in neurodegenerative disease: a case series of three nfvPPA-FTD patients | Di Donna, Mg; Colona, Vl; Bagnato, Mr; Bonomi, Cg; Tirrito, L; Marchionni, E; Motta, C; Sangiuolo, Fc; Martorana, A | Articolo su rivista | |
| 1-gen-2026 | Opposing patterns of blood-brain barrier permeability and Alzheimer’s disease biomarkers across APOE genotype | Bernocchi, F; Bonomi, Cg; Giuseppina, C; Poli, M; Di, D; Gaia, M; Terrinoni, A; Motta, C; Martorana, A | Articolo su rivista | |
| 1-gen-2025 | Reframing TDP‐43 in Alzheimer's disease: From co‐pathology to neurovascular culprit | Di Donna, Mg; Motta, C; Bonomi, Cg; Bernocchi, F; Ricci, F; Poli, M; Koch, G; Martorana, A | Articolo su rivista | |
| 1-gen-2025 | Reply to: letter to the editor regarding “beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies” | Poli, M; Bonomi, Cg; Di Donna, Mg; Motta, C; Martorana, A | Articolo su rivista | |
| 1-gen-2025 | Rethinking dementia in the oldest old: Lessons to learn for the diagnosis and treatment of Alzheimer’s disease | Bonomi, Cg; Motta, C; Di Donna, Mg; Poli, M; Koch, G; Martorana, A | Articolo su rivista | |
| 1-gen-2026 | Streamlining Alzheimer's disease diagnosis: real-world validation of two-cut-off diagnostic models based on plasma p-tau/Aβ42 ratios | Poli, M; Bonomi, C; Di Donna, Mg; Barberis, I; Ginevra, E; Nuccetelli, M; Bernardini, S; Centonze, D; Martorana, A; Motta, C | Articolo su rivista |